prepandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals
glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) - influenza, human; immunization; disease outbreaks - vaccines - active immunisation against h5n1 subtype of influenza a virus.this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of vaccine prepared from a/vietnam/1194/2004 nibrg-14 (h5n1) (see section 5.1).prepandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals 3.75 µg should be used in accordance with official guidance.
covid-19 vaccine (inactivated, adjuvanted) valneva
valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vaccines - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age. the use of this vaccine should be in accordance with official recommendations.
inactivated rabies vaccine merieux hdcv inj. sol. (pwdr. + solv.) i.m. vial + pre-filled syr.
sanofi pasteur europe s.a. - rabies virus (inactivated) ; albumin human 50 mg - powder and solvent for solution for injection - rabies virus, inactivated - rabies, inactivated, whole virus
coronavac suspension for injection covid-19 vaccine (vero cell) inactivated
pharmaniaga lifescience sdn. bhd. - inactivated sars-cov-2 virus (cz02 strain) (vero cell) -
coronavac suspension for injection covid-19 vaccine (vero cell) inactivated
pharmaniaga lifescience sdn. bhd. - inactivated sars-cov-2 virus (cz02 strain) (vero cell) -
covilo suspension for injection covid-19 vaccine (vero cell), inactivated
duopharma (m) sdn. bhd. - inactivated sars-cov-2 virus (19ncov-cdc-tan-hb02 strain) (vero cell) -
covaxin® (whole virion inactivated coronavirus (sars-cov-2) vaccine) suspension for intramuscular injection
averroes pharmaceuticals sdn. bhd. - inactivated whole sars-cov-2 virion (strain niv-2020-770) -
ap125rx inactivated actinobacillus pleuropneumoniae (total bacterial count) 41-1 strain (serotype 1) (seed), shp-1 strain 9serotype 2) (seed), ng-2 strain (serotype 5) (seed)- 1.0x10^9 ~5.0x10^9 cells each; non-toxigenic cytotoxic cytotoxins of actinobacillus pleuropneumoniae (derived from recombinant escherichia coli) rapx i protein (seed), rapx ii protein (seed), rapx iii protein (seed) - 80-120 mcg each suspension for injection (in
superiorvet inc.; distributor: superiorvet inc. - inactivated actinobacillus pleuropneumoniae vaccine (vet.) - suspension for injection (in - inactivated actinobacillus pleuropneumoniae (total bacterial count) 41-1 strain (serotype 1) (seed), shp-1 strain 9serotype 2) (seed), ng-2 strain (serotype 5) (seed)- 1.0x10^9 ~5.0x10^9 cells each; non-toxigenic cytotoxic cytotoxins of actinobacillus pleuropneumoniae (derived from recombinant escherichia coli) rapx i protein (seed), rapx ii protein (seed), rapx iii protein (seed) - 80-120 mcg each
avisan secure inactivated salmonella enteritidis ? 1/13 + inactivated salmonella typhimurium ? 1/40 parenteral ordinary vial
laboratorios hipra s.a - inactivated salmonella enteritidis pt-4 fagotype mat + inactivated salmonella typhimurium, dt-4 fagotype mat - parenteral ordinary vials - inactivated salmonella enteritidis ? 1/13 + inactivated salmonella typhimurium ? 1/40